Nearly every SaaS product is either integrating AI or planning to do so. However, the term “AI” has become so broad that it’s ...
Enterprise AI adoption surged in 2025, but scaling still lags. Explore 7 key enterprise AI adoption trends shaping 2026.
It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback